QCI Interpret

Visit us at AMP Europe 2018 and explore how QIAGEN Clinical Insight (QCI) Interpret can standardize your variant interpretation and reporting

QCI Interpret for somatic cancer is an integrated clinical decision support solution designed specifically for routine somatic cancer testing laboratories assessing next-generation sequencing (NGS) data. With QCI you can interpret and report NGS variants in the context of over 10 million relevant biomedical findings from the QIAGEN Knowledge Base, leveraging the experience of over 16+ years in manual curation. QCI allows you to minimize complexity, time and cost associated with determining clinical significance and action-ability of NGS variants.

register for a demo

See how advanced bioinformatics tools such as QCI-Interpret help to analyze and interpret vast amounts of genomic data to generate valuable insights.


QCI Interpret is an evidence-based decision support software intended as an aid in the interpretation of variants observed in genomic sequencing data. The software evaluates genomic variants in the context of published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and clinical-trials. Based on this evaluation, the software proposes a classification to aid in the interpretation of observed variants. The software is NOT intended as a primary diagnostic tool by physicians or to be used as a substitute for professional healthcare advice. Each laboratory is responsible for ensuring compliance with applicable international, national, and local clinical laboratory regulations and other specific accreditations requirements.

Visit us at AMP Europe 2018, booth #T19

Register for a demo
Social Sharing